FDA Approves Abbott’s FreeStyle Libre Pro System

The U.S. FDA has approved the Abbott’s FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with their patients with diabetes. FreeStyle Libre Pro system is designed to empower healthcare professionals to provide better diabetes management for diabetes … Read more

New Medtronic Guardian Connect Mobile CGM System Approved in EU

Medtronic has received CE (Conformité Européenne) Mark for its new Guardian Connect mobile continuous glucose monitoring (CGM) system for people with diabetes using insulin injection therapy. Guardian Connect is the first smartphone-enabled CGM system from Medtronic to receive CE Mark and … Read more

Want to Test Drive a CGM?

I learned about a trial with Medtronic’s iPro, a clinical version of a CGM, that’s inserted in the endocrinologist’s office, worn for three days, and then returned to the doctor. The data is then uploaded and analyzed to determine sufficient need for a CGM, warranting coverage by insurance. Read more

New CGM On The Way

After the NYC Marathon in November, I decided I really needed a CGM. But, as is often the case with resolutions, I didn’t do anything about it until last week when I decided I was going for it. Maybe the … Read more

FreeStyle Libre Approved for Kids in Europe

Abbott Diabetes Care announced that it has obtained CE Mark for the FreeStyle Libre flash glucose monitoring system indicated for children and teens with diabetes aged 4-17 years old. Read more

Making It Simple: Bigfoot’s Approach to the Artificial Pancreas

Bigfoot’s goal is to make pump-sensor therapy simpler than the pump companies before them have. They envision themselves as a service provider rather than a hardware or device company. Their service will be to “do a better job delivering insulin,” automating your between-meal insulin therapy, the communication between your pump and your Dexcom CGM, even so far as serving as a single point of contact for all of your supply and prescription inventory management, sending you supplies when you need them, “connecting everything, making it intuitive,” says Brewer. Read more

FDA Approves Animas Vibe and CGM for Children

The U.S. FDA has approved Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for management of diabetes in children and adolescents, ages 2 to 17. The Animas Vibe System was the first integrated system with Dexcom G4 PLATINUM … Read more

Subscribe to our Newsletter

Hide me